Emergent Biosolutions
EBS
EBS
275 hedge funds and large institutions have $2.79B invested in Emergent Biosolutions in 2018 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 91 increasing their positions, 106 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 263 → 275 (+12)
0.63% less ownership
Funds ownership: 85.45% → 84.83% (-0.63%)
14% less repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 106
Holders
275
Holding in Top 10
4
Calls
$3.22M
Puts
$2.22M
Top Buyers
| 1 | +$64.4M | |
| 2 | +$22.1M | |
| 3 | +$20.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$10.2M |
Top Sellers
| 1 | -$29M | |
| 2 | -$22.2M | |
| 3 | -$19M | |
| 4 |
Man Group
London,
United Kingdom
|
-$16.7M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$16.6M |